Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Júlia Elisa Hübner"'
Autor:
Vinicius Knackfuss Gonçalves, Fernando Sabino Marques Monteiro, Antonia Angeli Gazola, Felipe Pizzolo, Júlia Elisa Hübner, Rodrigo Pellegrini, Alessandra Borba, André P. Fay
Publikováno v:
Kidney Cancer. 6:129-136
BACKGROUND: Immune checkpoint inhibitors (ICI) have shown clinical benefit among patients with advanced kidney cancer. Their cost burden hardens its access, especially in low- and middle-income countries. To set solutions, the impact of geographical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb194583331c62ff99ca1eafb33f13c0
https://doi.org/10.3233/kca-210124
https://doi.org/10.3233/kca-210124
Autor:
Jose Gadu, Ricardo Castillejos, Carlos H. Scorticati, Felipe Pizzolo, Rodrigo Pellegrini, Marcos Tobias Machado, Carlos Ameri, Stenio de Cassio Zequi, Edgar Bravo, Pablo Mingote, Alberto Jurado, Walter da Costa, Andre P. Fay, Alejandro Nolazco, Roberto Puente, Luis Meza, Noelia Ferreira, Pablo Martínez, Francisco Rodríguez-Covarrubias, Luis Ubillos, Guillermo Gueglio, Ricardo Decia, Gustavo F. Carvalhal, Diego Muguruza, Diego Abreu, Antonia Angeli Gazola, Alessandra Borba Anton de Souza, Gustavo Cardoso Guimarães, Júlia Elisa Hübner, Oscar Rodríguez, Maximiliano Lopez, Nicolas Ginastar, Juan Yandian, Pablo M. Barrios, Alice Scalzilli Becker, Leandro Arribillaga, Rubén G. Bengió, Joan Palou, Rafael Alonso
Publikováno v:
Journal of Cancer Science and Clinical Therapeutics.
Background: Tumor burden and metastatic disease sites are well-established prognostic factors in many malignancies, including metastatic Renal Cell Carcinoma (mRCC). Objective: We aimed to evaluate the impact of bone metastasis (BM) location on clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a73597acf3a67d6f14914632277bc2b
https://doi.org/10.26502/jcsct.5079092
https://doi.org/10.26502/jcsct.5079092